"Generic and biosimilar savings help offset growing brand drug expenses, make medications more accessible for patients and support the sustainability of prescription benefits. This Capsule article explores metrics to monitor the use of generics and biosimilars, examines marketplace changes impacting these metrics and reviews benefit options that support the use of these lower-cost options. How close are your generic and biosimilar metrics to optimal performance levels?"  MORE >>